During tumour metabolic reprogramming, p53 regulates glycolysis by inhibiting the glucose transporters GLUT-1 and GLUT-4 and inducing the TP53-inducible glycolysis and apoptosis regulator (TIGAR). Here, TP53 is linked to neoplasm.